List of SBIR/STTR awards granted to Molecular Insight Pharmaceuticals, Inc.
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Molecular Insight Pharmaceuticals, Inc. for $1,617,727.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44CA142222-02A1 | Phase II | 1,617,727 | ||||||||
A STTR Phase I contract was awarded to Molecular Insight Pharmaceuticals, Inc. for $377,374.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41AI054080-01 | Phase I | 377,374 | ||||||||
A SBIR Phase I contract was awarded to Molecular Insight Pharmaceuticals, Inc. for $327,235.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43EB004253-01 | Phase I | 327,235 | ||||||||
A SBIR Phase I contract was awarded to Molecular Insight Pharmaceuticals, Inc. for $299,810.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R41CA112797-01 | Phase I | 299,810 | ||||||||
A STTR Phase I contract was awarded to Molecular Insight Pharmaceuticals, Inc. for $299,810.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41CA112797-01 | Phase I | 299,810 | ||||||||
A SBIR Phase II contract was awarded to Molecular Insight Pharmaceuticals, Inc. for $1,634,480.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44CA138041-02 | Phase II | 1,634,480 | ||||||||
A SBIR Phase I contract was awarded to Molecular Insight Pharmaceuticals, Inc. for $331,449.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44CA138041-01 | Phase I | 331,449 | ||||||||
A SBIR Phase I contract was awarded to Molecular Insight Pharmaceuticals, Inc. for $159,525.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL076972-01 | Phase I | 159,525 | ||||||||
A SBIR Phase I contract was awarded to Molecular Insight Pharmaceuticals, Inc. for $262,993.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA157090-01 | Phase I | 262,993 | ||||||||
A SBIR Phase I contract was awarded to Molecular Insight Pharmaceuticals, Inc. for $130,761.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44CA130394-01 | Phase I | 130,761 | ||||||||
A SBIR Phase I contract was awarded to Molecular Insight Pharmaceuticals, Inc. for $204,351.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA134013-01A1 | Phase I | 204,351 | ||||||||
A SBIR Phase II contract was awarded to Molecular Insight Pharmaceuticals, Inc. for $981,548.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44CA130394-02 | Phase II | 981,548 | ||||||||
A SBIR Phase I contract was awarded to Molecular Insight Pharmaceuticals, Inc. for $301,412.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HD046194-01 | Phase I | 301,412 | ||||||||
A SBIR Phase I contract was awarded to Molecular Insight Pharmaceuticals, Inc. for $130,387.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43EB005858-01 | Phase I | 130,387 | ||||||||
A SBIR Phase I contract was awarded to Molecular Insight Pharmaceuticals, Inc. for $180,916.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA141957-01 | Phase I | 180,916 | ||||||||
A SBIR Phase I contract was awarded to Molecular Insight Pharmaceuticals, Inc. for $337,713.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL075918-01 | Phase I | 337,713 | ||||||||
A SBIR Phase II contract was awarded to Molecular Insight Pharmaceuticals, Inc. for $925,243.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44CA115120-02 | Phase II | 925,243 | ||||||||
A SBIR Phase I contract was awarded to Molecular Insight Pharmaceuticals, Inc. for $243,101.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA150855-01 | Phase I | 243,101 | ||||||||
A SBIR Phase II contract was awarded to Molecular Insight Pharmaceuticals, Inc. for $1,935,675.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44CA157090-02 | Phase II | 1,935,675 | ||||||||
A SBIR Phase I contract was awarded to Molecular Insight Pharmaceuticals, Inc. for $223,985.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44CA141936-01 | Phase I | 223,985 | ||||||||
A SBIR Phase I contract was awarded to Molecular Insight Pharmaceuticals, Inc. for $147,491.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA115120-01 | Phase I | 147,491 | ||||||||
A SBIR Phase I contract was awarded to Molecular Insight Pharmaceuticals, Inc. for $164,108.0 USD from the U.S. Department of Health & Human Services. | SBIR | N43CM0622020C | Phase I | 164,108 | ||||||||
A SBIR Phase II contract was awarded to Molecular Insight Pharmaceuticals, Inc. for $1,296,830.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44CA141936-02 | Phase II | 1,296,830 | ||||||||
A SBIR Phase I contract was awarded to Molecular Insight Pharmaceuticals, Inc. for $190,643.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43NS046109-01 | Phase I | 190,643 |
